Current understandings of the trajectory and emerging correlates of cognitive impairment in bipolar disorder: An overview of evidence. (29th August 2019)

• Record Type: Journal Article
• Authors: Van Rheenen, Tamsyn E.; Lewandowski, Kathryn E.; Bauer, Isabelle E.; Kapczinski, Flavio; Miskowiak, Kamilla; Burdick, Katherine E.; Balanzá‐Martínez, Vicent
• Is Part Of: Bipolar disorders. Volume 22:Number 1(2020)
• Page Start: 13
• Page End: 27
• Publication Date: 2019-08-29
• Subjects: Manic-depressive illness -- Periodicals; Depression, Mental -- Periodicals; 616.895
• DOI: 10.1111/bdi.12821
• Languages: English
• ISSNs: 1398-5647

Abstract

Abstract: Objectives: Cognitive dysfunction affects a significant proportion of people with bipolar disorder (BD), but the cause, trajectory and correlates of such dysfunction remains unclear. Increased understanding of these factors is required to progress treatment development for this symptom dimension. Methods: This paper provides a critical overview of the literature concerning the trajectories and emerging correlates of cognitive functioning in BD. It is a narrative review in which we provide a qualitative synthesis of current evidence concerning clinical, molecular, neural and lifestyle correlates of cognitive impairment in BD across the lifespan (in premorbid, prodromal, early onset, post‐onset, elderly cohorts). Results: There is emerging evidence of empirical links between cognitive impairment and an increased inflammatory state, brain structural abnormalities and reduced neuroprotection in BD. However, evidence regarding the progressive nature of cognitive impairment is mixed, since consensus between different cross‐sectional data is lacking and does not align to the outcomes of the limited longitudinal studies available. Increased recognition of cognitive heterogeneity in BD may help to explain some inconsistencies in the extant literature. Conclusions: Large, longitudinally focussed studies of cognition and its covariation alongside biological and lifestyle factors are required to better define cognitive trajectories in BD, and eventually pave the way for the application of a precision medicine approach for individual patients in clinical practice.